Title
New-generation drug-eluting stents : focus on Xience V® everolimus-eluting stent and Resolute® zotarolimus-eluting stent New-generation drug-eluting stents : focus on Xience V® everolimus-eluting stent and Resolute® zotarolimus-eluting stent
Author
Faculty/Department
Faculty of Medicine and Health Sciences
Publication type
article
Publication
Mount Kisco, N.Y. ,
Subject
Human medicine
Source (journal)
Journal of interventional cardiology. - Mount Kisco, N.Y.
Volume/pages
26(2013) :3 , p. 278-286
ISSN
0896-4327
ISI
000320173700010
Carrier
E
Target language
English (eng)
Full text (Publishers DOI)
Affiliation
University of Antwerp
Abstract
Compared to bare metal stent angioplasty, first-generation drug-eluting stents (DES) have markedly reduced the incidence of in-stent restenosis. However, given the increased concerns over late and very late stent thrombosis, newer-generation DES were developed. To date, these DES have virtually replaced the use of first-generation DES worldwide. In this review article, we carefully consider the pre-clinical and clinical trials that have been performed with currently available, european conformity-marked and Food and Drug Administration-approved new-generation Resolute (R) and Xience V (R) DES. (J Interven Cardiol 2013;26:278-286)
E-info
https://repository.uantwerpen.be/docman/iruaauth/517ee5/0275089.pdf
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000320173700010&DestLinkType=RelatedRecords&DestApp=ALL_WOS&UsrCustomerID=ef845e08c439e550330acc77c7d2d848
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000320173700010&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=ef845e08c439e550330acc77c7d2d848
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000320173700010&DestLinkType=CitingArticles&DestApp=ALL_WOS&UsrCustomerID=ef845e08c439e550330acc77c7d2d848
Handle